These final results, together with a previous report exhibiting that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like conduct in mice,2 aid the strategy of targeting ACKR3 as a novel solution to modulate the opioid procedure, which could open up new therapeutic avenues for opioid-relevant Diseases. A new research exhibits https://albertm405ewn2.atualblog.com/profile